|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
2
|
|
pubmed:dateCreated |
2001-2-22
|
|
pubmed:abstractText |
Parkinson disease (PD) is often difficult to distinguish from parkinsonian syndromes of other causes in early stages of the disease. In search of a suitable endocrinologic challenge test, we investigated dopaminergic sensitivity in patients with de novo parkinsonian syndromes.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Feb
|
|
pubmed:issn |
0003-9942
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
58
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
241-6
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:11176962-Adrenocorticotropic Hormone,
pubmed-meshheading:11176962-Adult,
pubmed-meshheading:11176962-Aged,
pubmed-meshheading:11176962-Aged, 80 and over,
pubmed-meshheading:11176962-Analysis of Variance,
pubmed-meshheading:11176962-Antiparkinson Agents,
pubmed-meshheading:11176962-Apomorphine,
pubmed-meshheading:11176962-Female,
pubmed-meshheading:11176962-Growth Hormone,
pubmed-meshheading:11176962-Growth Hormone-Releasing Hormone,
pubmed-meshheading:11176962-Humans,
pubmed-meshheading:11176962-Hydrocortisone,
pubmed-meshheading:11176962-Male,
pubmed-meshheading:11176962-Middle Aged,
pubmed-meshheading:11176962-Multiple System Atrophy,
pubmed-meshheading:11176962-Parkinsonian Disorders,
pubmed-meshheading:11176962-Prolactin
|
|
pubmed:year |
2001
|
|
pubmed:articleTitle |
Increased growth hormone response to apomorphine in Parkinson disease compared with multiple system atrophy.
|
|
pubmed:affiliation |
Max Planck Institute of Psychiatry, Kraepelinstr 10, D-80804 Munich, Germany. friess@mpipsykl.mpg.de
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial
|
